Transcript No Slide Title

Science, research and development
European Commission
Life Sciences, Genomics and
Biotechnology for Health
Dr Alfredo Aguilar
Head of Unit
Biotechnology and Applied Genomics
Research Directorate General
European Commission
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Framework Programme 2002-2006
Focussing and Integrating Community Research
• 7 priority areas
To assemble a critical mass of resources and
support integration of EU research capacities in
To structure the ERA in:
• Research & Innovation
• Training & Mobility
• Infrastructures
• Science & Society
Structuring ERA
• supporting policies and
anticipating needs
• SME
• International cooperation
• JRC (non-nuclear research)
• To co-ordinate EU research activities
• To support the development of
research/innovation policies
Strenghtening the ERA Foundations
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
7 Priority Thematic Areas
Budget proposed
(EUR million)
1. Life Sciences, Genomics and Biotechnology
for Health
2. Information Society Technologies
3. Nanotechnologies, Multifunctional Materials
and New Production Systems and devices
3625
4. Aeronautics and Space
1075
5. Food Quality and Safety
6. Sustainable Development,Global Change and
Ecosystems
7. Citizens and Governance in a Knowledge Society
2255
1300
685
2120
225
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Framework Programme 6 (2002-2006)
Thematic priorities
Focus on strategic areas where immediate and longer
term integration of European research is needed to
generate and sustain necessary critical mass
New knowledge >> understanding >>application
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Priority ‘Life Sciences, Genomics
and Biotechnology for Health’
To help Europe to exploit breakthroughs in
decoding the genomes of living organisms
for the benefit of :
- public health
- citizens
- increase the competitiveness of European
biotechnology industry
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Priority 1: Life Sciences, Genomics and
Biotechnology for Health
Advanced genomics and its application for health
(1100 Millions Euros):
• Fundamental knowledge and basic tools for functional genomics in all
organisms
• Applications of knowledge and technologies in the field of genomics and
biotechnology for health
Combating major diseases (1155 Millions Euros):
• Application-oriented genomic approaches to medical knowledge and
technologies
• Confronting the major communicable diseases linked to poverty
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Fundamental knowledge and basic tools for
functional genomics in all organisms
Objective: Understanding of genomic information, by developing the
knowledge base, tools and resources needed to decipher the function of
genes and gene products.
- Research actions: gene expression and proteomics
- Structural genomics
- Comparative genomics
- Comparative genomics and population genetics
- Bioinformatics
- Multidisciplinary functional genomics approaches to basic biological
process
APPLICATIONS
Medicine
Quality of Life
Agriculture
Environment
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Applications of knowledge and technologies
in the field of genomics and biotechnology for health (i)
Objective: Foster the competitiveness of Europe’s biotechnology industry by
exploiting the wealth of biological data produced by genomics and advances
in biotechnology.
- Research actions: Technological platforms for the development in the
fields of new diagnostics, prevention and therapeutic tools
APPLICATIONS
Health
Care
Cost
Reduction
Diagnostics
Individualised
treatment
New drugs
and therapies
… with an active and early involvement of regulators, experts on ethics,
patients and society at large.
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Applications of knowledge and technologies
in the field of genomics and biotechnology for health (ii)
 Technological platforms for developments in the field of new
diagnostic, prevention and therapeutic tools :
•
•
•
•
•
•
Rational and accelerated development of new, safer, more
effective drugs including pharmacogenomics approaches
Development of new diagnostics
Development of new in vitro tests to replace animal testing
Development and testing of new preventive and therapeutic tools
(such as somatic gene and cell therapies [stem cells therapies])
Immunotherapies
Innovative research in post-genomics, which has high potential for
application
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Application-oriented genomic approaches
to medical knowledge and technologies
Objective: to develop improved strategies for the prevention and
management of human disease and for living and ageing healthy.
Research actions:
- Combating cardiovascular diseases, diabetes and rare diseases
- Combating resistance to antibiotics and other drugs
- Studying the brain and combating diseases of the nervous system
- Studying human development and the ageing process
- Combating cancer
APPLICATIONS
Bringing basic knowledge
through to clinical applications
Improved patientoriented strategies
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Confronting the major communicable
diseases linked to poverty
Objective:
To confront the global emergency caused by the three
major communicable diseases HIV/AIDS, malaria and
tuberculosis through the development of effective disease
interventions, particularly for use in developing countries.
Chile-EC S&T Agreement
Brussels, 24 September 2002
Science, research and development
European Commission
Opportunities for Life Sciences,
Genomics and Biotechnology for Health
in Framework Programme 6 (2002-2006)
Ongoing and coming trends...
• 7 June 2002 deadline for the “Invitation to submit Expressions of Interest”.
• November 2002, First Call for Proposals, Framework Programme 6
To keep you informed with the latest news…
www.cordis.lu/fp6/eoi-instruments
… and with the new instruments, rules for participation,…
http://europa.eu.int/comm/research/nfp/networks-ip.html
Help and information :
for Priority “Life Sciences, Genomics and Biotechnology for Health”:
[email protected]
Chile-EC S&T Agreement
Brussels, 24 September 2002